Company registration number 13972139 (England and Wales)
ISOMAB LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
ISOMAB LTD
STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2026
31 March 2026
- 1 -
2026
2025
£
£
£
£
Fixed assets
10,582
16,244
Current assets
3,446,945
4,153,633
Prepayments and accrued income
10,438
174,276
Creditors: amounts falling due within one year
(2,713,866)
(475,592)
Net current assets
743,517
3,852,317
Total assets less current liabilities
754,099
3,868,561
Accruals and deferred income
(163,477)
(23,619)
Net assets
590,622
3,844,942
Equity
590,622
3,844,942
Notes to the financial statements
1
General information
Isomab Ltd is a private company, limited by shares, incorporated in England & Wales, registered number
13972139. The registered office is St Johns Innovation Centre, Cowley Road, Cambridge, CB4 0WS.
2
Average number of employees
Average number of employees, including directors, during the year was: 9 (2025: 9)
For the year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime', and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the income statement within the financial statements.true
ISOMAB LTD
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2026
31 March 2026
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 26 August 2026 and are signed on its behalf by:
P M Edwards
Director
Company registration number 13972139 (England and Wales)